Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00053001
Status:
COMPLETED
Last Update Posted:
2013-06-26
First Post:
2003-01-27
Brief Title:
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
Sponsor:
Fallon Clinic
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MyelodysplasticMyeloproliferative Neoplasms |
| Anemia |
| Leukemia |
| Myelodysplastic Syndromes |
Keywords:
| Name | View |
|---|---|
| de novo myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |
| previously treated myelodysplastic syndromes | View |
| anemia | View |
| atypical chronic myeloid leukemia BCR-ABL1 negative | View |
| myelodysplasticmyeloproliferative neoplasm unclassifiable | View |
| childhood myelodysplastic syndromes | View |